The HIV In My Day project preserves the early history of the HIV/AIDS pandemic through the personal stories of long-term survivors and caregivers.
One of the main challenges remains that diagnostics and drugs for people suffering from advanced HIV aren't readily available. This group of people is vulnerable to deadly opportunistic infections.
The British press ignored the millions of deaths from HIV/Aids in Africa for far too long.
Uganda's COVID-19 task force would do well to embrace pop music in its public health communications.
The South African National Defence Force has suffered from terrible neglect over the past 25 years of democracy.
Women and children remain the focus of HIV while men are disadvantaged in accessing testing and treatment in Africa.
HIV self-testing is a potential strategy to overcome access to testing. However, there are emerging concerns on the lack of counselling, possible user error and accuracy of the kits.
South Africa's data rollout of its pre-exposure prophylaxis shows that there is a relatively slow, but increasing, uptake. However, more needs to be done to target young women.
Three new HIV vaccine concepts which rely on high-tech designer proteins are being trialled to see if they can stop the virus.
Understanding where there are high numbers of new HIV infections is important to establishing whether interventions are working or not.
South Africa has made tremendous progress towards meeting the 90-90-90 targets but there are some challenges preventing it from reaching the goals set by UNAIDS.
A South African child, who has been in HIV remission for nearly nine years, could help researchers understand how to make remission possible for millions of other HIV positive people.
Climate change imperils food supply in many parts of the world, including South Africa, which has shown major gains in treating HIV/AIDS. Climate change could mean even less food -- and more disease.
After nearly two decades of legal battles and negotiations, South Africa is moving to cut the cost of medicines with policies to increase imports and local production of generic drugs.